Expand All | Collapse All
Jeffrey S. Berns, MD, Chair
Dr. Berns is Professor of Medicine and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, where he is Associate Dean for Graduate Medical Education, Associate Chief of the Renal, Electrolyte, and Hypertension Division, and Director of the Nephrology Fellowship Training Program. Dr. Berns maintains a general nephrology practice at the Hospital of the University of Pennsylvania. He is a board certified internist and nephrologist.
Dr. Berns was in private practice, first in Northern Virginia, then in Philadelphia, for about 12 years before joining the faculty of the University of Pennsylvania in 1999.
Dr. Berns serves as Dialysis Section co-Editor for UpToDate, and is Co-Deputy Editor of American Journal of Kidney Diseses. He is Chair of the ABIM Council and also Chair of the American Board of Internal Medicine's (ABIM) Nephrology Specialty Board. He also served on the ABIM Nephrology Board Exam Committee and the ABIM Nephrology Self-Assessment Committee. He is Immediate Past President of the National Kidney Foundation. He has received numerous teaching awards, including the Christian R. and Mary F. Lindback Award for Distinguished Teaching from the University of Pennsylvania. He is also the recipient of the Exemplar of Humanism in Medicine Award from the College of Physicians of Philadelphia. He has been regularly honored in Philadelphia Magazine as a “Philadelphia Top Doc” and as one of America's “Top Docs” in nephrology.
Dr. Berns received his medical degree from Case Western Reserve University in Cleveland, Ohio. He completed his internal medicine internship at University Hospitals of Cleveland and then his nephrology fellowship at Yale University.
As of March 2019, Dr. Berns reported the following external relationships:
Work as an author or editor for following companies, with compensation as listed:
- American Journal of Kidney Diseases, receiving compensation as Deputy Editor.
- UpToDate, receiving compensation for authorship and editorial services.
Bruce A. Leff, MD, Chair-Elect
Dr. Leff is a board certified internist and geriatrician and Professor of Medicine at the Johns Hopkins University School of Medicine in the Division of Geriatric Medicine and Gerontology. He holds a joint appointment in the Department of Health Policy and Management at the Johns Hopkins University Bloomberg School of Public Health, and in the Johns Hopkins School of Nursing, Department of Community and Public Health.
He is the Director of the Center on Aging and Health Program in Geriatric Health Services Research and the co-Director of the Elder House Call Program. His principal areas of health services research relate to the development, evaluation and dissemination of innovative models of health service delivery for older adults, issues related to the care of people with multiple chronic conditions, the development of quality indicators for home-based medical care, guideline development and case-mix issues. He is the author of more than 100 peer-reviewed publications and book chapters. Dr. Leff has a strong interest in health policy and is a recent health and aging policy fellow and has served on multiple National Quality Forum and Centers for Medicare & Medicaid Services Technical Expert Panels. Dr. Leff cares for patients in the acute, ambulatory and home settings.
The Chair-Elect of the American Board of Internal Medicine (ABIM) Council, Dr. Leff is also Chair of the ABIM Geriatric Medicine Board. He directs the medicine clerkship at the Johns Hopkins University School of Medicine and has received multiple awards for his teaching and mentorship. He is a member of the Board of Regents of the American College of Physicians, as well as past-President and current board member of the American Academy of Home Care Physicians.
Dr. Leff received his medical degree from the New York University School of Medicine and completed residency in primary care internal medicine at the Johns Hopkins Bayview Medical Center, and a fellowship in geriatric medicine and gerontology at the Johns Hopkins University School of Medicine, in Baltimore.
As of February 2019, Dr. Leff reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Johns Hopkins University, from the following company:
- National Institutes of Health (NIH), trial of a non-drug intervention for patients with dementia.
Work as an author or editor for the following company, with compensation as listed:
- Springer Publishing, Co-Editor of book on geriatric home-based medical care.
Dr. Leff holds a license on Hospital at Home, with income related to licensing technical materials to health systems, receiving royalties.
Dr. Leff serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Alliance for Home Health Quality and Innovation, Member of Board of Directors, receiving reimbursement for travel.
- American Academy of Home Care Physicians, Member of Board of Directors, receiving reimbursement for travel.
- Ascension Health, Member of the Quality Committee to the Board of Directors, receiving reimbursement for travel.
- Landmark Health, LLC, serving on the advisory board of a not-for-profit home health care company, receiving reimbursement for travel expenses and honoraria.
- Veterans Affairs, Member of the VA Geriatrics and Gerontology Advisory Committee, receiving reimbursement for travel.
Dr. Leff reported receiving grant funding from The Commonwealth Fund, The Retirement Research Fund, the John A. Hartford Foundation, Patient-Centered Outcomes Research Institute, National Institute of Aging, and California Healthcare Foundation, all paid to Johns Hopkins University.
Dr. Leff also reported being a member of the Clinical Advisory Board for Medically Home and Dispatch Health.
George M. Abraham, MD, MPH
Dr. Abraham is Professor of Medicine at the University of Massachusetts Medical School, Chief of Medicine at Saint Vincent Hospital, Worcester, Massachusetts and Adjunct Professor at the Massachusetts College of Pharmacy and Health Sciences (MCPHS). He is board certified in Internal Medicine and Infectious Disease.
Currently, Dr. Abraham is a member of the ABIM Council and Chair of the American Board of Internal Medicine Infectious Disease Board. He serves as the Chair of the Board of Governors and a Regent of the American College of Physicians (ACP) and also serves on several of its committees. He also is Vice-Chair of the Board of Registration (Licensing) in Medicine, Massachusetts. Prior to this, he has served as a Trustee of the Massachusetts Medical Society, as President of the Worcester District Medical Society, as the Chief Medical Officer of the Central Massachusetts Independent Physician Association and Chair of the Board of Directors of the Health Foundation of Central Massachusetts.
He has received several awards including the Alpha Omega Alpha Volunteer Faculty Award and the Outstanding Primary Care Educator Award of University of Massachusetts Medical School; the Leadership Award of the Massachusetts chapter of the ACP; and the Phi Lambda Sigma honorary Membership, MCPHS, Worcester, Massachusetts, among others
His research interests include hepatitis C and B disease, travel medicine and infection control, as well as medication safety and systems improvement. He has authored several publications, abstracts and book chapters, and presented at national and international meetings.
Dr. Abraham earned his medical degree from the Christian Medical College, India, completed his residency and chief residency at Saint Vincent Hospital, and received his master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health.
As of February 2019, Dr. Abraham reported the following external relationships:
Dr. Abraham serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- American College of Physicians, Massachusetts Chapter Governor, Member of Board of Regents; Chair, Board of Governors, receiving reimbursement for travel expenses.
Olakunle Akinboboye, MD
Dr. Akinboboye is board certified in Cardiovascular Disease and Sleep Medicine. He is a Clinical Associate Professor of Medicine at New York University (NYU). He is also the Medical Director of Queens Heart Institute/Laurelton Heart Specialist P.C. in Rosedale, Queens, New York.
Dr. Akinboboye is Chair of the American Board of Internal Medicine Cardiovascular Board and a member of the ABIM Council. He is also a member of the Association of Black Cardiologists (ABC) Executive Committee, where he serves as Chair of the Clinical Trials Committee. He also serves on the International Board of Governors of the American College of Cardiology (Liaison for Africa). He served as the President of the ABC from 2012 to 2014.
He received a humanitarian award from the College of Medicine at University of Ibadan in Nigeria in 2005 for his ongoing efforts to spread expertise in the techniques of cardiopulmonary resuscitation in Nigeria. He also received an award from ABC for his dedicated service as a board member from 1999 to 2005.
Dr. Akinboboye received his medical degree from the College of Medicine at the University of Ibadan. He completed his internal medicine residency and part of his cardiology fellowship at the Nassau County Medical Center, State University of New York at Stony Brook. He subsequently moved to Columbia University, where he completed his fellowship in cardiology with one year of dedicated training in nuclear cardiology and another year of training in advanced echocardiography. Dr. Akinboboye obtained a master's degree in public health from Columbia University. He also received a master’s degree in business administration from Columbia Business School.
As of April 2019, Dr. Akinboboye reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Queens Heart Institute, from the following companies:
- AstraZeneca, for a study of the effects of exenatide in lowering cardiovascular events in patients with type 2 diabetes mellitus (EXSCEL).
- Novartis, for a study of the effectiveness of angiotensin-neprilysin inhibition versus enalapril in heart failure (PARADIGM-HF).
Attendance at investigators’ meetings, with compensation for travel expenses from the following companies:
- Cytokinetics, for a study to evaluate the effect of treatment with omecamtiv mecarbil compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing following 20 weeks of treatment with omecamtiv mecarbil or placebo.
Ashok Balasubramanyam, MD
Dr. Balasubramanyam, a board certified internist and endocrinologist, is Professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, Vice President for Academic Integration and Senior Associate Dean for Academic Affairs at Baylor College of Medicine, Houston. His academic career involves basic and translational research in diabetes and metabolic diseases, education (including service as past director of the endocrine fellowship program and current director of Baylor’s Clinical Scientist Training Program), and clinical practice as an internist and endocrine consultant.
Currently, Dr. Balasubramanyam serves as a member of the ABIM Council and the Chair of the Endocrinology, Disease, and Metabolism Board of the American Board of Internal Medicine. He is a past president of the Association of Program Directors in Endocrinology and Metabolism.
Dr. Balasubramanyam earned his undergraduate degree at Yale University and his medical degree at St. John’s Medical College, Bangalore, India. He completed residency training and was Chief Resident at Baylor College of Medicine, and completed clinical and research fellowship training in endocrinology at the Massachusetts General Hospital, Boston.
As of April 2019, Dr. Balasubramanyam reported the following external relationship:
Work as an author or editor for the following company, with compensation as listed below:
- UpToDate, receiving compensation for authorship.
Dr. Balasubramanyam serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Harris County Medical Society, Board Member, without compensation.
Marcy B. Bolster, MD
Dr. Bolster is an Associate Professor of Medicine at Harvard Medical School. She is the Director of the rheumatology fellowship training program in the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital (MGH). She is a board certified rheumatologist.
Prior to her position at MGH, she was a Professor of Medicine, Division of Rheumatology, at the Medical University of South Carolina (MUSC), where she was on faculty from 1993-2012. She also served as the Director of the rheumatology fellowship training program; the Medical Director of the Center for Osteoporosis and Bone Health and the Medical Director of the Musculoskeletal Institute at MUSC.
She is a fellow of the American College of Physicians and of the American College of Rheumatology (ACR), a member of the International Society for Clinical Densitometry and a member of the American Society for Bone Mineral Research. She is Chair, ACR Committee on Training and Workforce (COTW). She has served as co-leader for the ACR in the ACGME Next Accreditation System. She is a member of both the ACR and the Rheumatology Research Foundation Boards of Directors. She has served on the American Board of Internal Medicine (ABIM) Rheumatology Board and is currently its Chair. She is also the Chair of the ABIM Rheumatology Board Exam Committee, serves as a member of the ABIM Council and is the incoming Chair of the ABIM Exam Chairs Committee. She is a member of the MGH Department of Medicine Education Council and Innovation in Education Committee. She previously served as the co-Chairperson for the Rheumatology In-Training Examination and on the ACR COTW, chairing the Sub-Committee on Resident Education, spearheading the development of “Rheum2Learn”, an online internal medicine resident education tool for rheumatology.
She obtained a bachelor of arts degree in chemistry and her medical degree from Duke University. She trained in internal medicine at the Eastern Virginia Graduate School of Medicine and obtained rheumatology training at MUSC.
As of April 2019, Dr. Bolster reported the following external relationships:
Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:
- Gilead, for service on an advisory board.
Work funded by educational grants from industry, paid directly to Massachusetts General Hospital Rheumatology, from the following company:
- Amgen, providing partial salary support for a rheumatology fellow through the Rheumatology Research Foundation; funding is used solely for a fellow's salary support.
- AbbVie/Pfizer, providing an educational grant to support a winter symposium for five rheumatology fellowship training programs; funding is used solely for a fellow's salary support.
Susan Edgman-Levitan, PA
Ms. Edgman-Levitan is Executive Director of the John D. Stoeckle Center for Primary Care Innovation at Massachusetts General Hospital (MGH). Prior to coming to MGH, she was the founding President of the Picker Institute. She is a lecturer in the Department of Medicine, Massachusetts General Hospital and an Associate in Health Policy, Harvard Medical School.
A constant advocate of understanding the patient's perspective on health care, Ms. Edgman-Levitan has been the co-Principal Investigator on the Harvard Consumer Assessment of Health Plans Study (CAHPS) from 1995 to the present and she is the Institute for Healthcare Improvement Fellow for Patient and Family-Centered Care. She is an editor of “Through the Patient's Eyes,” a book on creating and sustaining patient centered care, “The CAHPS Improvement Guide,” and has authored many papers and other publications on patient-centered care. She is a co-author of the Institute of Medicine 2006 report, The Future of Drug Safety: Promoting and Protecting the Health of the Public.
Ms. Edgman-Levitan serves on several boards and national advisory committees, including the Foundation for Informed Medical Decision Making, the National Patient Safety Foundation, the National Health Services Corps Advisory Council, the Patient-Centered Primary Care Collaborative, and is a member of the Lucian Leape Institute. She also serves on the American Board of Internal Medicine Council.
Ms. Edgman-Levitan is a graduate of the University of Michigan and the Duke University Physician Assistant program where she received the Distinguished Alumni Award from the Duke Physician Assistant Program and was inducted into the Duke University Medical Center Hall of Fame in 2004. Ms. Edgman-Levitan was awarded the 2007 Leadership and Innovation award from the Center for Information Therapy.
As of June 2019, Ms. Edgman-Levitan reported the following external relationships:
Ms. Edgman-Levitan serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- Patient-Centered Primary Care Collaborative, serving as a Board Member, receiving no compensation.
Serpil C. Erzurum, MD
Dr. Erzurum is the Alfred Lerner Memorial Chair in Innovative Biomedical Research of the Department of Pathobiology in the Lerner Research Institute, and the Program Director of the Cleveland Clinic Clinical Research Unit of the Case Clinical Translational Science Center. In these roles, she led development of translational multidisciplinary research programs to investigate human diseases. Since 1993, she has practiced as an ABIM Board Certified pulmonologist at the Cleveland Clinic. She also holds certifications in internal medicine and critical care medicine.
Prior to the Cleveland Clinic, Dr Erzurum practiced at the University of Pittsburgh Medical Center, in the Indian Health Service in South Dakota, and as a senior staff fellow in the pulmonary branch of the National Heart Lung and Blood Institute (NHLBI). Over the past 25 years, her National Institutes of Health-funded studies of asthma and pulmonary vascular diseases have uncovered mechanisms and led to new therapeutic concepts.
She is a member of the Board of External Experts and Board of Scientific Counselors for NHLBI, and a Councilor of the Association of American Physicians. Dr. Erzurum chairs the research committee of the Scientific Leadership Council of the Pulmonary Hypertension Association and has been a senior fellow of the American Asthma Foundation. She is deputy editor of the American Journal of Respiratory and Critical Care Medicine since 2009. She serves on the American Board of Internal Medicine (ABIM) Council, is Chair of the ABIM Pulmonary Disease Board and is a member of the ABIM Pulmonary Disease Board Exam Committee.
Dr. Erzurum received her medical degree in 1983 from Northeastern Ohio Universities College of Medicine. Following medicine residency at Baylor College of Medicine, she trained in pulmonary and critical care at the University of Colorado and National Jewish Center.
As of February 2019, Dr. Erzurum reported the following external relationship:
Dr. Erzurum reported receiving grant funding from the National Institutes of Health for staff, salary support, and project expenses.
J. Christopher Farmer, MD
Dr. Farmer is a board certified internist and critical care physician. He serves as Professor and Chair, Department of Critical Care Medicine, Mayo Clinic Arizona. He previously served at Mayo Clinic in Rochester, Minnesota as Critical Care Medicine Fellowship Program Director, Associate Dean, Mayo School of Graduate Medical Education, and Associate Chair for Education, Department of Medicine.
Dr. Farmer is a retired Air Force Colonel and Professor of Medicine and Surgery, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine. He also served as a senior physician executive in the hospital, health plans-insurance, supply chain management and homeland security sectors. He is one of the founders of the Department of Defense Critical Care Aeromedical Transport Team program, the largest critical care transport system in the world. While in the Air Force, Dr. Farmer served as Chief of Inpatient Services at Wilford Hall Medical Center, and as Chief Medical Officer for TRICARE Southwest, a multi-state federal HMO. He also served as the Special Assistant to the Air Force Surgeon General for Homeland Defense and Medical Preparedness.
Dr. Farmer is a member of the American Board of Internal Medicine (ABIM) Critical Care Medicine Board and serves on the ABIM Critical Care Medicine Self-Assessment Committee. He was the 2014 President of the Society of Critical Care Medicine (SCCM) and has served as SCCM Council Member and Treasurer, Program Chair, SCCM Congress, Founding Editor-in-Chief, Multidisciplinary Critical Care Knowledge Assessment Program, Supplements Editor, Critical Care Medicine, and textbook editor, Fundamental Critical Care Support and Fundamental Disaster Management programs. He is the editor and author of numerous books related to critical care, education and disaster medical response.
Dr. Farmer holds a bachelor's degree in biology from Texas A&M University, where he also earned his medical degree. He completed residency at Wilford Hall Medical Center in the United States Air Force and a fellowship in critical care medicine at St. Louis University and St. Johns Mercy Medical Center.
As of February 2019, Dr. Farmer reported no external relationships.
Tommye Lambert, MDiv
Ms. Lambert is the Founder and President of Live and Proclaim Ministries. Prior to this, for 28 years, Ms. Lambert was the primary caregiver to her daughter, who suffered with cystic fibrosis. During that time, she interacted with pulmonary care clinicians at five centers, including critical care and transplant teams. She was a leader in the caregiver community providing training and facilitating discussions focused on assisting in improved patient care through patient-doctor communication and collaboration. She serves as a member of the American Board of Internal Medicine Council and also serves on the American Board of Internal Medicine as an At-Large Member of the Pulmonary Disease Board.
Since 2002, Ms. Lambert has focused her work on the compassionate care of the community as a member of the clergy. She has served as minister to adults at Hunter Street Baptist Church, addressing the educational and counseling needs of single adults, women and married couples in a congregation of 7,000. During her tenure, the church has published a variety of biblically based curricula, small group lessons and inspirational devotional journals written and edited by Ms. Lambert.
Prior to clergy service, Ms. Lambert worked in clinical laboratory medicine for 17 years. The last 10 years of her health care career, she served at Roche Biomedical Laboratories, Clinical Laboratory Division as the General Regional Manager, Southeastern Region, Regional Project Manager and the Regional Training Director.
Ms. Lambert earned a master's degree in divinity at Beeson Divinity School, Samford University; an executive MBA from the University of Alabama; and a bachelor's degree in medical technology from the University of Southern Mississippi. She is pursuing a Doctor of Ministry at Beeson Divinity School. Her dissertation research is related to the application of theology in daily living (Christian ethics), and her upcoming praxis will be based upon the ethical decisions pursuant to the challenges of daily life and end-of-life decisions of the chronically ill.
As of April 2019, Ms. Lambert reported no external relationships.
Michael E. Nelson, MD
Dr. Nelson is a practicing physician in Shawnee Mission, Kansas. He is a member of the staff of Shawnee Mission Medical Center, where he has previously served as the Chairman of the Department of Internal Medicine. He is currently the Medical Director of the Sleep Laboratory. His certifications from the American Board of Internal Medicine (ABIM) include Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine. He also holds a certification in Sleep Medicine from the American Board of Sleep Medicine.
Currently, Dr. Nelson serves as a member of the American Board of Internal Medicine Council and Pulmonary Disease Board. He is also a member of the Education Committee and the Clinical Practice Committee of the American Thoracic Society (ATS). He has been an active participant in the educational programs of the American College of Physicians and the American College of Chest Physicians (ACCP). Dr. Nelson serves as the Alternate Advisor to the American Medical Association's Current Procedural Terminology Committee for the ACCP and the ATS.
Dr. Nelson earned his medical degree at the University of Kansas School of Medicine. He completed his residency and chief residency in internal medicine, as well as a fellowship in pulmonary and critical care medicine, at the Department of Medicine at the University of Kansas.
As of May 2019, Dr. Nelson reported the following external relationships:
Dr. Nelson serves in significant roles with the following healthcare-related organizations, receiving reimbursement or compensation as listed:
- American College of Chest Physicians, President, Board of Trustees of CHEST Foundation, Board of Regents, receiving reimbursement for travel expenses.
- Medical Education Resources, lectures on pulmonary disease and sleep medicine, receiving reimbursement for travel expenses and honoraria.
- The National Association for Medical Direction of Respiratory Care, Member of Board of Directors, without compensation.
Jane E. Onken, MD
Dr. Onken is an Associate Professor of Medicine, Division of Gastroenterology at Duke University Medical Center. She is Director of the Inflammatory Bowel Disease clinic at Duke and on faculty at the Duke Clinical Research Institute. She is board certified in Gastroenterology.
Dr. Onken is Chair of the American Board of Internal Medicine Gastroenterology Board and a member of the ABIM Council. She recently completed a three-year term as Chair of the Education and Training Committee of the American Gastroenterological Association (AGA). During that term, she served on the AGA’s Leadership Cabinet, the MOC Task Force, and the board of the Academy of Educators. She has chaired the AGA Training Subcommittee and has been a member of the Graduate Training Examination Subcommittee. In 2013, she was selected to join the multi-society Oversight Working Network Committee, a group that designed the Entrustable Professional Activities currently in use by training programs in Gastroenterology. At Duke, she was recently elected for a fourth term to the University's Academic Council and has served on the Executive Committee of the Academic Council. Dr. Onken is a former program director for the Duke Gastroenterology Fellowship program. She is a member of the Leadership Board of the Triangle Chapter of the Crohn’s and Colitis Foundation of America (CCFA) and is a recipient of the CCFA Premier Physician Award.
Dr. Onken received her undergraduate degree from Smith College and attended the George Washington University School of Medicine. She completed her house staff training in internal medicine at Duke University, followed by fellowship training in gastroenterology. She received a master’s degree in health sciences from Duke in 2005.
As of May 2019, Dr. Onken reported the following external relationships:
Funding for clinical trial expenses, staff and salary support, paid to Duke University, from the following company:
- Boehringer Ingelheim, for a phase II/III clnical trial in patients with moderate to severe ulcerative colitis.
- Janssen, for phase I clinical trial of ustekinumab in Crohn's disease.
- Seres, for a clinical trial investigating fecal replacement for patients with mild-to-moderate ulcerative colitis.
Work funded by educational grants from industry, paid to Duke University, from the following company:
- Takeda, to create two dinner symposia updating community providers on irritable bowel disease, and two podcasts related to irritable bowel disease.
Dr. Onken serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- American Gastroenterological Association, Special Section Editor of Education and Training, receiving honoraria.
John J. Oppenheimer, MD
Dr. Oppenheimer is the Director of Clinical Research at Pulmonary and Allergy Associates as well as Clinical Professor of Medicine at UMDNJ-Rutgers He is board certified in Internal Medicine and Allergy and Immunology. He trained and was on faculty at the National Jewish Center in Denver Colorado. Dr. Oppenheimer has participated in over 100 clinical studies with over 200 publications. He serves as the Associate Editor of the Annals of Allergy Asthma and Immunology, co-section editor of Current Reports of Allergy and Immunology, Current Opinion of Allergy and Immunology and serves as a reviewer for several journals including the Journal of Allergy and Clinical Immunology and JAMA. He also serves as a member of the American Board of Internal Medicine Council.
He is the past Chairman of the ADT section as well as the Interest Section Coordinating Committee of the AAAAI, serves on the Joint Task Force of the Practice Parameter Committee for Allergy Immunology, the writing committee of the cough guidelines committee for the American College of Chest Physicians, a voting member of PCPI and member of the measures development for atopic dermatitis, was on the Board of Directors of the American Board of Allergy and Immunology 2010-2015 and is the past Chairman of the ABAI. He has focused his career on guideline development and has been actively involved in measurement development in the field of allergy and immunology.
As of June 2019, Dr. Oppenheimer reported the following external relationships:
Preclinical research, with funding for salary support, from the following companies:
- AbbVie, for evaluation of potential anaphylaxis.
Funding for clinical trial expenses and staff, paid to Pulmonary and Allergy Associates, P.A., from the following companies:
- Genentech, for a study on long-term safety of omalizumab.
Attendance at investigators’ meetings, with compensation for travel expenses from the following companies:
- Novartis, regarding omalizumab.
Service on data and safety monitoring boards for the following companies, with and honoraria:
- AstraZeneca, chair of tezepelumab adjudication committee.
- GlaxoSmithKline, regarding mepolizumab.
- Sangamo, regarding dupilumab.
Service on a research-related expert panel or advisory board for the following companies, without compensation:
- GlaxoSmithKline, for advising on a closed triple pivotal trial design.
Robert D. Siegel, MD
Dr. Siegel, a board certified internist, hematologist and medical oncologist is the Oncology Program Director for the Bon Secours St. Francis Health System in Greenville, South Carolina. Prior to his appointment to program leadership at St. Francis, Dr. Siegel had been a community based oncologist with particular interest in quality improvement initiatives and cancer care delivery research.
Dr. Siegel has served the ABIM as a member of the Medical Oncology Exam Writing Committee and is currently a member of the Specialty Board in Medical Oncology. In July, 2015, he was elected to serve on the ABIM Board of Directors. He has previously served as the Co-Chair of the Quality of Care Subcommittee for the NCI Community Cancer Centers Program (NCCCP) and is currently on the Executive Committee for SCOR (Southeast Consortium for Oncology Research).
Dr. Siegel earned his medical degree at the Columbia University College of Physicians and Surgeons and did his internal medicine training at Barnes Hospital/Washington University in St. Louis. He completed his fellowship training in medical oncology and hematology at the Dana Farber Cancer Institute/ Brigham and Women's Hospital/ Harvard University.
As of April 2019, Dr. Siegel reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Bon Secours St. Francis Hospital, from the following companies:
- Bristol-Myers Squibb, for a lung cancer clinical trial, kidney cancer clinical trial, and for a non-Hodgkin lymphoma clinical trial.
- Cancer Insight, for a melanoma clinical trial.
- Non-Hodgin's lymphomas.
- Mirati Therapeutics, for a clinical trial for solid tumors.
- Biodesix, for an observational study assessing the clinical effectiveness of validating immunotherapy tests in subject with non-small cell lung cancer.
- CerRX Inc., for a Phase II trial of intravenous fenretinide emulsion for patients with relapsed/refractory peripheral T-cell lymphomas.
- Boston Biomedical, for a Phase II trial of metastatic pancreatic ductal adenocarcinoma.
- GRAIL, Inc., for a trial of use deep sequencing of circulating cell-free nucleic acids to develop assays to detect cancer early in blood.
- Pharmatech, for a trial of the treatment of cutaneous T-cell lymphoma.
Dr. Siegel serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society for Clinical Oncology, Chair of Quality Oncology Practice Initiative Certification Oversight Committee, receiving reimbursement for travel expenses.
- Guardian Research Network, Board of Directors, without compensation.
Asher A. Tulsky, MD
Dr. Tulsky is a board certified internist. He is Associate Professor of Medicine at the Boston University School of Medicine and Associate Chief of Education in the section of General Internal Medicine. His career has focused on postgraduate medical education, and he is currently Director of Resident Development at Boston Medical Center.
Previously, he was associate program director at the University of Pittsburgh Internal Medicine Residency program, directed their community-based residency program, established and directed the International Scholars Program for gifted and accomplished international medical graduates pursuing academic medicine careers and was the principal consultant in a collaboration between the University of Pittsburgh and the Teine Keijinkai Hospital in Sapporo, Japan, in establishing a U.S.-modeled internal medicine residency program.
A member of the American Board of Internal Medicine's (ABIM) Council, Dr. Tulsky is also Chair of the American Board of Internal Medicine's (ABIM) Internal Medicine Specialty Board and served for eight years on the ABIM Internal Medicine Board Exam Committee. He is also an active member of the Association of Program Directors of Internal Medicine.
Dr. Tulsky earned his medical degree from the Chicago Medical School, completed internal medicine residency training at the Michael Reese Hospital and Medical Center in Chicago and fellowship in general internal medicine at the University of Rochester School of Medicine and Dentistry.
As of February 2019, Dr. Tulsky reported the following external relationships:
Dr. Tulsky serves in a significant role with the following organization, receiving reimbursement or compensation as listed:
- Alliance for Academic Internal Medicine, Program Planning Committee, without compensation.
Mark M. Udden, MD
Dr. Udden, a board certified hematologist and internist, is Chief of Benign Hematology and Professor of Medicine at Baylor College of Medicine (BCM) in Houston, Texas. He is Chief of Hematology at the Ben Taub General Hospital and Harris Health Smith Clinic. He is also an Attending Physician in the Baylor Clinic and consults at Baylor Saint Luke’s Medical Center and the Texas Children’s Hospital Pavilion for Women. He has a special interest in sickle cell disease and hematology of pregnancy. He also co-chairs the second-year medical student course in hematology/oncology and has an active teaching role for resident and fellowship training at Baylor.
He has served at Baylor as Core Clerkship Director for Internal Medicine from 1990 to 2007 and Chairman of the Longitudinal Ambulatory Care Experience course from 1994 to 1999. He was an Adjunct Assistant then Associate Professor in the Biomedical Engineering Department at Rice University from 1983 until 1992.
Dr. Udden is Chair of the American Board of Internal Medicine (ABIM) Hematology Board. He is also Chair of the ABIM Hematology Board Exam Committee. He is a fellow of the American College of Physicians. At Baylor, he has received numerous teaching awards including the Barbara and Corbin J. Robertson, Jr. Presidential Award for Excellence in Education in 2008 and the Master Clinician Lifetime Award in 2013.
He received his undergraduate degree from the Massachusetts Institute of Technology and his medical degree from The University of Texas Southwestern Medical School. He completed his residency in internal medicine and a fellowship in hematology at Baylor College of Medicine.
As of March 2019, Dr. Udden reported no external relationships.